Finance

Lists
Why is 300436 down 2.06%?
Dive Deeper
300436:SHE
Fujian Cosunter Pharmaceutical Co Ltd
CNÂ¥80.00
-2.06%
(-1.68) 1D
Oct 16, 3:04:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300436...
Open
CNÂ¥82.09
High
CNÂ¥85.89
Low
CNÂ¥79.83
Mkt. cap
13.72B
Avg. vol.
2.69M
Volume
4.57M
52-wk high
CNÂ¥149.00
52-wk low
CNÂ¥73.60
EPS
-CNÂ¥1.38
Shares outstanding
168.03M
No. of employees
715
Open
CNÂ¥82.09
High
CNÂ¥85.89
Low
CNÂ¥79.83
Mkt. cap
13.72B
Avg. vol.
2.69M
Volume
4.57M
52-wk high
CNÂ¥149.00
52-wk low
CNÂ¥73.60
EPS
-CNÂ¥1.38
Shares outstanding
168.03M
No. of employees
715
News stories
From web sources and news partners
About Fujian Cosunter Pharmaceutical Co Ltd
CEO-
Employees715
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitecosunter.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
106.98M
100.54M
98.44M
121.71M
Cost of goods sold
32.68M
71.64M
32.53M
74.28M
Cost of revenue
32.68M
71.64M
32.53M
74.28M
Research and development expenses
12.80M
4.28M
13.49M
9.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.44M
78.09M
69.44M
72.06M
Operating expense
100.11M
85.32M
83.15M
85.73M
Total operating expenses
132.79M
156.96M
115.68M
160.01M
Operating income
-25.81M
-56.43M
-17.24M
-38.29M
Other non operating income
-987.89K
768.31K
-72.70K
-220.40K
EBT including unusual items
-44.63M
-122.10M
-27.04M
-41.74M
EBT excluding unusual items
-37.13M
-64.23M
-25.93M
-47.53M
Income tax expense
3.86M
835.64K
3.08M
4.16M
Effective tax rate
-8.64%
-0.68%
-11.38%
-9.97%
Other operating expenses
1.75M
2.27M
-90.80K
4.35M
Net income
-44.90M
-106.26M
-25.92M
-42.21M
Net profit margin
-41.97%
-105.70%
-26.34%
-34.68%
Earnings per share
-
-
-
-
Interest and investment income
13.03K
30.43K
134.30K
-
Interest expense
-8.30M
-7.88M
-8.75M
-9.10M
Net interest expenses
-8.29M
-7.85M
-8.62M
-9.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.17M
-33.43M
5.76M
-19.57M
Gain or loss from assets sale
-
-9.89K
-
201.00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps